PE29.5 | Klinefelter Syndrome — Summary & Reflection

KEY TAKEAWAYS

Klinefelter syndrome (47,XXY) is the most common sex-chromosome aneuploidy in males (~1 in 500–600 live male births) and the most common genetic cause of non-obstructive azoospermia and male hypogonadism. The extra X chromosome causes seminiferous tubule hyalinisation → azoospermia; Leydig cell dysfunction → low testosterone → elevated FSH/LH (hypergonadotropic hypogonadism); and increased peripheral aromatisation → gynaecomastia. Cardinal features: tall stature (long limbs), small firm testes (<4 mL bilaterally post-puberty), incomplete virilisation, gynaecomastia, and language/learning difficulties. Hormonal profile: elevated FSH/LH, low testosterone, low inhibin B, normal or elevated oestradiol. Management: testosterone replacement from early puberty (~11–12 years) for virilisation and bone protection; TESE + ICSI for fertility (~50% sperm retrieval rate). Testosterone replacement suppresses residual spermatogenesis — fertility planning must precede testosterone initiation. Recurrence risk in future pregnancies is not elevated above background.

REFLECT

Consider the 16-year-old from the opening hook. He is about to receive a diagnosis that will explain why he looks different from his peers, and that will tell him he will likely be infertile. He is also 16 — old enough to understand the implications but still navigating identity and self-image. How do you balance the clinical necessity of complete disclosure with sensitivity to his developmental stage? Should the initial diagnosis conversation be with the parents present, with him alone, or with both together? Reflect on what aspects of this consultation would be hardest for you personally — the medical complexity, the emotional content, or something else — and write three sentences in your learning journal about how you would prepare for it.